专题：2025可持续全球领导者大会&首届绿色产业与可持续消费博览会 炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 10月16日至18日，2025可持续全球领导者大会在上海世博园区召开。粤开证券董事长郭川舟受邀出席大 会，并做主旨演讲。 他介绍，粤开证券背靠广州经开区——这一粤港澳大湾区内经济总量与科技创新水平均位居前列的核心 区域。基于此，公司在服务科技金融方面主要从三个层面展开，其中"转型"是首要任务。自2017年起， 集团及粤开证券在战略与主营业务上实现了全面转型。八年来，通过持续收购与整合，包括完成对粤开 证券的并购，公司构建了新的主营业务生态，目前旗下拥有三家上市公司，覆盖能源发电、生物医疗器 械及新能源板块，并成功发行了广东省首单产业园区REIT。集团亦是中国服务业企业500强及全国唯一 一家"双百企业"区属国企。 在服务科技产业的具体模式上，郭川舟指出是以"投资引领"为核心。他举例称，自并购粤开证券后，投 资板块持续聚焦"高精尖"领域，代表性项目包括投资了科创板生物医药市值领军企业百济神州，以及小 鹏汽车、文远知行等知名公司。持续的收并购不仅是资产提升、实现产业投资退出 ...

Core Insights - Shanghai has approved a total of 30 domestically developed Class 1 innovative drugs from 2021 to September 2025, leading the nation in drug and medical device innovation [1] - The Shanghai government is committed to accelerating the entire chain of biopharmaceutical innovation, including basic research, incubation, clinical trials, regulatory approval, production, and application [1] - The establishment of various funds, including a 225 billion yuan biopharmaceutical industry mother fund and a 150 billion yuan future industry fund, aims to support long-term investments in the biopharmaceutical sector [3][4] Investment and Funding - The Shanghai National Investment Biopharmaceutical Industry Ecosystem Cooperation Fund was signed during the event, emphasizing the importance of patient capital in the high-risk, high-investment biopharmaceutical industry [2] - As of October 2023, the total investment decision in biopharmaceutical sub-funds by the Shanghai biopharmaceutical mother fund and other funds has reached approximately 6.6 billion yuan, with a market selection of 22 sub-funds [4] - The funds focus on innovative drug and medical device supply chains, brain-computer interfaces, synthetic biology, and other cutting-edge technologies [4] Industry Development - The Zhangjiang Pharma Valley has approved 30 Class 1 innovative drugs and 37 innovative medical devices, showcasing significant progress in the biopharmaceutical sector [9] - The Shanghai region has attracted over 50% of the capital for the biopharmaceutical industry, facilitating both research and commercialization efforts [9] - The connection between original innovation and application is emphasized, with institutions acting as bridges to transition basic research into viable drug products [10] Future Directions - The focus for the next 5-10 years will be on transforming original innovation capabilities into drug forms, which is seen as a critical development direction [10] - A comprehensive service center has been established to support the entire process from idea generation to approval and industrialization [10]

Core Viewpoint - Beijing's implementation plan aims to accelerate the construction of a technology finance system to support high-level technological self-reliance and strength from 2025 to 2027, aligning with national policies and local innovation goals [1][2]. Overall Goals - The plan targets the establishment of a comprehensive technology finance service system, enhancing financial services for national laboratories and leading technology enterprises, with a goal to exceed 10 trillion yuan in newly established funds by 2027 [3]. - By the end of 2027, the balance of technology loans and loans to technology enterprises is expected to surpass 5.5 trillion yuan and 2.5 trillion yuan respectively, with annual growth rates exceeding national and municipal averages [3]. Venture Capital Support - The plan emphasizes securing various national-level funds to be established in Beijing, enhancing financial support for major technological breakthroughs and original innovations [4]. - It aims to deepen pilot projects for financial asset investment companies, targeting a total cooperative fund scale of no less than 50 billion yuan by 2027 [5]. Monetary and Credit Support - The plan intends to leverage structural monetary policy tools to support technology innovation financing, aiming to mobilize no less than 100 billion yuan annually for related loans [7]. - It proposes optimizing evaluation models for technology enterprises to improve credit access and enhance the precision of financial services [7]. Capital Market Support - The initiative seeks to support high-quality technology enterprises in listing, utilizing capital market reforms to facilitate their growth and financing [10]. - It plans to establish a "Zhongguancun Technology Board" for issuing technology innovation bonds, enhancing the registration and issuance process [10]. Technology Insurance Role - The plan encourages the development of insurance products that cover the entire cycle of technological innovation, aiming to provide comprehensive risk protection for technology enterprises [12]. Fiscal Policy Guidance - It emphasizes the use of fiscal funds to amplify and guide technology finance, supporting financing guarantees for technology enterprises [13]. Open Innovation Ecosystem - The plan aims to enhance the convenience of cross-border fund usage and promote international cooperation in technology finance, encouraging foreign investment in local technology enterprises [14][15]. Organizational Implementation - The plan outlines a coordinated mechanism for implementing technology finance initiatives, establishing a comprehensive evaluation system for financial institutions' contributions to technological innovation [16][17].

Core Viewpoint - The article emphasizes the importance of capital market reforms in supporting technological innovation and industrial transformation during China's "14th Five-Year Plan" period, highlighting the role of the Science and Technology Innovation Board (STAR Market) and the Growth Enterprise Market (GEM) in enhancing the adaptability of the multi-level market system [1][2]. Group 1: Capital Market Reforms - The capital market is enhancing its inclusivity to support high-tech, high-growth, and high-risk enterprises, providing a full chain of services from venture capital to IPO financing and mergers and acquisitions [2][3]. - The introduction of the registration system in the STAR Market and GEM has significantly improved the inclusivity of the listing process, with over 90% of new listings during the "14th Five-Year Plan" being high-tech enterprises [3][4]. - As of now, the market capitalization of the technology sector in A-shares exceeds 25%, surpassing the combined market capitalization of the banking, non-banking financial, and real estate sectors [4]. Group 2: Private Equity and Venture Capital - Private equity and venture capital funds have accelerated their development, becoming key drivers of technological innovation and industrial transformation, with a management scale of 14.4 trillion yuan and 150,000 projects under investment as of Q2 2023 [6][7]. - These funds have invested in 90% of companies listed on the STAR Market and the Beijing Stock Exchange, demonstrating their role as incubators and accelerators for innovation [7]. - The government has introduced supportive policies to optimize the venture capital ecosystem, enhancing fundraising, investment, and exit mechanisms [6]. Group 3: Quality of Listed Companies - The cultivation of new productive forces relies on high-quality listed companies, with regulatory measures in place to enhance information disclosure, corporate governance, and market-oriented mergers and acquisitions [8][9]. - In 2023, over 2 trillion yuan in cash dividends were distributed by listed companies, reflecting a commitment to shareholder returns and market stability [9]. - The number of major asset restructurings has increased significantly, with 1,234 disclosures in the first eight months of the year, indicating a trend towards optimizing resource allocation through mergers and acquisitions [9][10].

Core Points - Beijing aims to introduce over 1 trillion RMB in long-term and patient capital into the technology innovation sector by the end of 2027 [1] - The plan includes promoting technology innovation bonds, technology insurance, and the issuance of REITs, positioning Beijing as a leader in these areas nationally [1] - The initiative seeks to attract national venture capital guidance funds and enhance financial support for major technological breakthroughs and core technologies [1] Group 1 - The plan emphasizes support for high-quality technology companies to go public and encourages quality overseas-listed companies to return to domestic markets [1] - Beijing will leverage the Beijing Stock Exchange as a testing ground for reforms, providing tailored services for companies involved in significant technological challenges and breakthroughs [1] - The establishment of a "Zhongguancun Technology Bond" is proposed to facilitate the issuance of technology innovation bonds by various financial entities [2] Group 2 - The initiative promotes international cooperation in technology finance, encouraging foreign venture capital and private equity firms to establish branches in Beijing [2] - The plan aims to enhance collaboration between domestic and foreign financial institutions and to guide foreign capital to invest in Beijing's technology innovation sector [2] - There is a focus on cultivating international technology finance talent to support these initiatives [2]

Core Viewpoint - The establishment of the Gobi-Redbird Innovation Fund (Gobi-RIF) aims to support early-stage startups incubated by the Hong Kong University of Science and Technology, focusing on the commercialization of cutting-edge academic research and accelerating the global market entry of university research outcomes [1][2]. Group 1: Fund Details - Gobi-RIF is a strategic fund with a duration of 7 to 8 years, targeting the commercialization of research outcomes in four key areas: biotechnology, Industry 4.0, artificial intelligence (AI) and robotics, and fintech [1]. - The fund aims to invest in 15 to 20 startups, having already invested in 3 companies, including Lai Mou Technology (robotic lawnmowers), Atom Semiconductor (waferless design), and Starry Sky Cloud Knowledge (satellite solutions) [1]. - Gobi-RIF will invest in companies at the A to C funding stages, with individual investments amounting to several million dollars, and is seeking additional patient capital investors [1]. Group 2: Objectives and Impact - The primary goal of Gobi-RIF is to support the development of tech startups and create a lasting impact, while also ensuring financial returns to sustain further investments in other startups [2]. - The fund is expected to drive a flywheel effect of talent, capital, and opportunities, with a focus on discovering the next generation of talent and companies [2]. - The fund aims to attract more patient capital, promote deep integration of industry, academia, and research, and leverage Hong Kong's international market advantages to connect invested companies with global markets and resources [3].

Core Viewpoint - The article highlights the resurgence of the primary market in Hong Kong, emphasizing the strategic collaboration between Hong Kong University of Science and Technology (HKUST), Hong Kong Investment Company, and Gobi Partners to establish a new venture capital fund aimed at fostering early-stage startups with a focus on technology innovation [2][4][18]. Group 1: Fund Establishment and Objectives - The "Gobi-Redbird Innovation Fund" has been established to nurture early-stage startups incubated by HKUST, targeting a portfolio of 15 to 20 companies with a projected return rate of 20% over a tracking period of approximately 7 to 8 years [5][6]. - The fund aims to accelerate the commercialization of research outcomes in four key areas: biotechnology, Industry 4.0, artificial intelligence (AI) and robotics, and fintech [5][6]. Group 2: Market Dynamics and Trends - The article notes a significant shift in the investment landscape, with an increasing number of venture capital firms, particularly those associated with universities, entering the market, reflecting a new force in the venture capital sector [11][12]. - There is a marked increase in the attractiveness of the Hong Kong market, driven by a surge in IPO activity and improved exit channels for investment institutions [6][7]. Group 3: Policy and Strategic Initiatives - The Hong Kong government is actively promoting innovation and technology development, with plans to establish new research institutes and funds aimed at strategic emerging industries by 2026-2027 [7][8]. - The collaboration between HKUST, Gobi Partners, and Hong Kong Investment Company is seen as a critical strategic move to build a resilient innovation ecosystem in Hong Kong [8][18]. Group 4: Investment Logic and Future Outlook - The investment logic is evolving, with a focus on "hard technology" sectors such as robotics, semiconductors, and AI, moving away from previous models of innovation that were more accessible to a broader range of participants [13][14]. - The concept of "patient capital" is emerging as a stabilizing force in the market, emphasizing the need for clear strategies and excellent performance from fund managers [15][16]. Group 5: Implications for Stakeholders - The collaboration signifies a shift towards deep value investment and a commitment to supporting the real economy, indicating a promising era for technology-driven entrepreneurs [18][19]. - For general partners (GPs) and investors, there is a necessity to deepen industry engagement and enhance their ability to assess cutting-edge technologies to seize opportunities effectively [18].

Core Insights - Suzhou Angel Fund has successfully navigated the challenges of early-stage investment, achieving notable results with six of its invested companies listed among Jiangsu's unicorns, contributing to Suzhou's leading position with a total of 38 unicorns [1] Group 1: Investment Strategy - The fund focuses on "early and small" investments, defined by a strict "522" standard: companies must be less than 5 years old, have fewer than 200 employees, and a net asset or sales revenue of no more than 20 million yuan [2] - The fund operates through a "sub-fund + direct investment" model, emphasizing risk management and partner selection based on capability, structure, and values alignment [2] Group 2: Risk Management - The fund employs a comprehensive risk management system, including a four-tier decision-making process and a focus on project sourcing through industry research and ecological networks [2] - Investment amounts are capped at 20 million yuan per project, with a focus on portfolio diversification and active post-investment management [3] Group 3: Valuation and Exit Strategies - To address valuation challenges, the fund emphasizes "pricing" over rigid "valuation," using methods like cost anchoring and milestone-based payments to mitigate risks associated with high initial valuations [3] - The fund adopts a multi-faceted exit strategy, exploring various channels beyond IPOs, including S fund transfers and industry mergers, to enhance liquidity [3] Group 4: Ecosystem Development - The fund fosters collaboration through a network of partners, organizing over 30 investment and financing events annually, and has established "Angel Bay" to support over 100 tech companies in Suzhou [5] - Financial innovation is highlighted through partnerships with banks to provide funding support, with approximately 9 billion yuan in credit extended to early-stage companies [5] Group 5: Future Outlook - The fund plans to enhance its management capabilities and expand its scale, with intentions to establish a second phase of the Angel Fund and collaborate with well-known institutions in key industrial sectors [5][6]

Group 1 - The article discusses the establishment of the first cross-provincial fiscal and tax sharing fund in China, initiated by the financial departments of Jiangsu, Zhejiang, and Shanghai [4][6]. - The fund, named the Yangtze River Delta Ecological Green Integrated Development Demonstration Zone Investment Fund, has an initial scale of 500 million yuan (approximately 71 million USD) and focuses on green low-carbon and technological innovation investments [6][7]. - This fund represents a significant innovation in resource allocation, aiming to support high-quality development in cross-provincial high-tech zones and promote a fiscal sharing mechanism among the involved regions [7][8]. Group 2 - The article highlights the increasing activity and scale of policy-oriented Limited Partners (LPs) in the investment market, with a reported 8% month-on-month growth in total investment scale as of August [10]. - Financial institution LPs have shown a notable increase in activity, with a 36% rise in investment scale, while financial LPs' activity increased by 7% and their scale surged by 119% [10][11]. - The concept of "patient capital" is gaining traction, with many mother funds extending their duration to 15-20 years, reflecting a shift towards a more flexible and supportive investment environment [12][13].

炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 证券时报记者 马静 中央经济工作会议将"壮大耐心资本""梯度培育创新型企业"作为2025年要抓好的重点任务。张明表示，财达证券坚持长期主义，以投资为着力点，引导优质金融资源向科创领域集聚。 一方面，加大对优质科技企业的投资倾斜，支持科技企业降低融资成本。去年以来，财达证券资管产品投资科创债28.86亿元，其中河北省内科创债达23.25亿元；自有资金投资科创债近9.15 另一方面，通过二级市场投资、新三板做市，为科技企业债券、股票在二级市场提供流动性支持。财达证券已累计做市新三板项目68个，目前正持续为19家专精特新、高新技术、制造业单项冠 财达证券还以股权创投基金为孵化器，整合协同社会资本聚焦投早、投小、投长期、投硬科技，加大对科技企业进行前期培育。目前，规模3亿元的财达宝堃（雄安）科创股权投资基金已经完成 此外，财达证券聚焦区域重点产业集群和科技型企业，常态化开展"走进燕赵大地"大型调研活动。近两年，财达证券引入近百家金融机构深入调研河北企业，着力发挥券商链接融资端和投资端的 做强研究引擎： 为科技金融提供基础支撑 助力科技型企业成长 ...